Heron Therapeutics, Inc. (HRTX) Balance Sheet
As of 2026-06-30 (10-Q), Heron Therapeutics, Inc. (HRTX) reported total assets of $252.3M, total liabilities of $245.4M and shareholders' equity of $6.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $20.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HRTXHeron Therapeutics, Inc.Follow HRTX — free
—
Price chart with a free account
- Market cap
- 57.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 18.0 | 53.5 | 72.3 | 72.7 | 75.2 | 13.4 | 144.6 | 31.8 | 71.9 | 105.1 | 90.5 | 15.4 | 28.7 | 25.8 | 28.6 | 20.7 | |
| Short-term investments | — | — | — | 0.0 | 56.0 | 37.7 | 27.8 | 300.5 | 319.1 | 103.4 | 67.0 | 69.5 | 51.7 | 33.5 | 18.0 | 21.9 | |
| Receivables | — | — | — | — | — | 2.0 | 41.9 | 64.7 | 39.9 | 41.9 | 35.5 | 52.0 | 60.1 | 78.9 | 89.6 | 89.6 | |
| Inventory | — | — | — | — | — | 5.3 | 10.1 | 39.0 | 25.0 | 41.9 | 48.4 | 54.6 | 42.1 | 53.2 | 92.7 | 90.6 | |
| Current assets | 18.2 | 54.1 | 72.9 | 73.7 | 134.8 | 62.1 | 228.1 | 447.2 | 479.1 | 314.2 | 254.4 | 205.4 | 188.8 | 209.0 | 238.1 | 229.8 | |
| Total assets | 19.4 | 56.0 | 75.9 | 76.7 | 137.8 | 67.5 | 234.3 | 462.2 | 512.8 | 353.6 | 305.7 | 251.0 | 222.5 | 233.1 | 255.9 | 252.3 | |
| Current liabilities | 3.7 | 4.2 | 7.0 | 13.6 | 19.7 | 38.7 | 103.2 | 92.0 | 96.7 | 102.5 | 71.1 | 82.4 | 79.7 | 91.5 | 96.1 | 92.1 | |
| Total liabilities | 3.7 | — | — | — | 19.7 | 88.7 | 103.2 | 92.0 | 108.9 | 117.1 | 228.1 | 237.4 | 256.5 | 266.8 | 241.5 | 245.4 | |
| Shareholders' equity | 15.8 | 51.8 | 68.9 | 63.1 | 118.1 | -21.3 | 131.1 | 370.2 | 403.8 | 236.5 | 77.6 | 13.6 | -34.0 | -33.7 | 14.3 | 6.9 |
USD millions · SEC XBRL
Heron Therapeutics, Inc. — questions
- How much cash does Heron Therapeutics, Inc. have?
- $20.7M in cash and cash equivalents as of 2026-06-30.
- What are Heron Therapeutics, Inc.'s total assets?
- $252.3M as of 2026-06-30.
- What is Heron Therapeutics, Inc.'s shareholders' equity?
- $6.9M as of 2026-06-30.
Every figure on this page comes from Heron Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.